# Ketamine Infusion for Rapid Reduction of Suicidality in Pediatrics

> **NCT04955470** · PHASE1,PHASE2 · TERMINATED · sponsor: **University of British Columbia** · enrollment: 15 (actual)

## Conditions studied

- Suicidal Ideation

## Interventions

- **DRUG:** Ketamine Injectable Solution
- **DRUG:** Midazolam Injectable Solution
- **DRUG:** Normal Saline 0.9% Injectable Solution

## Key facts

- **NCT ID:** NCT04955470
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-06-01
- **Primary completion:** 2023-09-01
- **Final completion:** 2023-10-01
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** There were challenges with recruitment in the ED due to ED staffing shortages and we were unable to meet the expected recruitment rate. The decision to stop study recruitment was solely due to operational and logistical limitations.
- **Last updated:** 2024-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04955470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04955470, "Ketamine Infusion for Rapid Reduction of Suicidality in Pediatrics". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04955470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*